AlEid, Ahmad;
Al Balkhi, Areej;
Qutub, Adel;
Abbarh, Shahem;
AlLehibi, Abed;
Almtawa, Abdullah;
Al Otaibi, Nawwaf;
AlGhamdi, Ahmed;
AlGhamdi, Adel;
Alamr, Abdulrahman;
Ahmad, Shameem;
Al Sayari, Khalid;
Al Ibrahim, Bashaar;
AlKhathlan, Abdullah
The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial
Beteiligte:
AlEid, Ahmad;
Al Balkhi, Areej;
Qutub, Adel;
Abbarh, Shahem;
AlLehibi, Abed;
Almtawa, Abdullah;
Al Otaibi, Nawwaf;
AlGhamdi, Ahmed;
AlGhamdi, Adel;
Alamr, Abdulrahman;
Ahmad, Shameem;
Al Sayari, Khalid;
Al Ibrahim, Bashaar;
AlKhathlan, Abdullah
Erschienen:
Medknow, 2022
Erschienen in:
Saudi Journal of Gastroenterology, 28 (2022) 3, Seite 225